Australia markets closed

Healthcare & Medical Investment Corporation (3455.T)

Tokyo - Tokyo Delayed price. Currency in JPY
Add to watchlist
131,500.00-1,300.00 (-0.98%)
At close: 03:15PM JST
Currency in JPY

Valuation measures4

Market cap (intra-day) 47.27B
Enterprise value 84.88B
Trailing P/E 19.87
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)9.45
Price/book (mrq)1.21
Enterprise value/revenue 21.22
Enterprise value/EBITDA 29.11

Trading information

Stock price history

Beta (5Y monthly) 0.21
52-week change 3-21.35%
S&P500 52-week change 326.27%
52-week high 3169,900.00
52-week low 3125,100.00
50-day moving average 3131,422.00
200-day moving average 3139,325.50

Share statistics

Avg vol (3-month) 31.01k
Avg vol (10-day) 3573
Shares outstanding 5359.5k
Implied shares outstanding 6367.75k
Float 8355.5k
% held by insiders 16.61%
% held by institutions 156.31%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 46470
Forward annual dividend yield 44.92%
Trailing annual dividend rate 36,517.00
Trailing annual dividend yield 34.91%
5-year average dividend yield 44.62
Payout ratio 4104.60%
Dividend date 3N/A
Ex-dividend date 430 July 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Jan 2024
Most-recent quarter (mrq)31 Jan 2024

Profitability

Profit margin 43.42%
Operating margin (ttm)51.43%

Management effectiveness

Return on assets (ttm)1.95%
Return on equity (ttm)5.46%

Income statement

Revenue (ttm)4.88B
Revenue per share (ttm)13,565.92
Quarterly revenue growth (yoy)-7.40%
Gross profit (ttm)N/A
EBITDA 3.65B
Net income avi to common (ttm)2.12B
Diluted EPS (ttm)6,614.45
Quarterly earnings growth (yoy)-17.90%

Balance sheet

Total cash (mrq)1.87B
Total cash per share (mrq)5,188.52
Total debt (mrq)39.15B
Total debt/equity (mrq)101.59%
Current ratio (mrq)0.28
Book value per share (mrq)107,196.07

Cash flow statement

Operating cash flow (ttm)3.29B
Levered free cash flow (ttm)2.43B